Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

3.59
Delayed Data
As of 4:00pm ET
 -0.04 / -1.10%
Today’s Change
3.18
Today|||52-Week Range
10.98
-16.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization489.0K512.0K613.0K642.0K
 
 
 
 
 
 
Operating ExpensesGross Income-489.0K-512.0K-613.0K-642.0K
 
 
 
 
 
General Expenses40.7M49.8M32.2M46.0M
 
 
 
 
 
Research And Development33.2M41.9M23.5M29.0M
 
 
 
 
 
Total Operating Expenses41.2M50.3M32.8M46.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-41.2M-50.3M-32.8M-46.6M
 
 
 
 
 
Extraordinary Credit2.3M796.0K128.0K1.5M
 
 
 
 
 
Extraordinary Charge0.00-500.0K0.00-19.7M
 
 
 
Other Expenses42.0K3.0K7.0K-18.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-38.8M-50.0M-32.6M-64.6M
 
 
 
 
 
Income Taxes0.000.000.00-6.9M
 
 
Preferred Dividend0.000.000.00-2.6M
 
 
Net Income-38.8M-50.0M-32.6M-57.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS62.4M77.6M96.6M19.3M
 
 
 
 
 
Shares To Calculate EPS Diluted62.4M77.6M96.6M19.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.62-$0.64-$0.34-$3.13
 
 
 
 
 
EPS Diluted-$0.62-$0.64-$0.34-$3.13